Corrigendum to “Yi-Qi-Xuan-Fei formula ameliorate chronic obstructive pulmonary disease by remodeling lung and intestinal florase in rat models” [J Food Drug Anal 33(3) (2025) 252–276]

1. The description in Figure 3D of Result 3.3 should be

…The results demonstrated that the CD11c-positive staining area increased in the model group compared with the control group, whereas it decreased in all treatment dosage groups compared with the model group (Fig. 3D). These findings suggest that…

2. The description in Figure 8B and C of Result 3.8 should be

…YQXF, at medium or high doses, significantly increased the levels of Alloprevotella spp., Roseburia spp., and Lactobacillus spp. in the intestines, and of Lactobacillus spp. in the lungs (P < 0.05). Oscillibacter spp. did not show a statistically significant increase or decrease in the intestines, but the levels of Oscillibacter spp. showed a significant increase in the lungs after treatment with YQXF at the low dose (P < 0.05) (Fig. 8B and C). The abundance of Escherichia/Shigella and Clostridium sensu stricto was elevated in the intestinal flora of the model group (P < 0.05). YQXF responded to the increased abundance of Fusobacterium and Clostridium sensu stricto in both the lungs and intestines (P < 0.05). It showed no reaction to the increased abundance of Escherichia/Shigella in the lungs, whereas it responded to their increased abundance in the intestines (P < 0.01) (Fig. 8D and E). These results indicate that, although the species and location…